This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

FDA Approves Drug Which Makes Lung Cancer Glow

Friday, January 6, 2023

Submitted by


Victoria Forster

The FDA has approved the drug Cytalux for use in lung surgery. The drug, also known as pafolacianine, binds to lung cancer cells to make them glow under infrared light. Surgical removal of lung tumors before they spread to the rest of the body remains one of the most effective ways to treat the disease, so the availability of this drug has major implications for lung cancer patient outcomes.

Add comment

Log in or register to post comments